SOBI:STO
Swedish Orphan Biovitrum AB (publ)
SEKÂ 427.20
arrow_downward
-1.48%(-6.40) 1D
Oct 13, 5:29:57 PM GMT+2 · SEK
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for SOBI...
Open
SEKÂ 433.60
High
SEKÂ 437.40
Low
SEKÂ 420.40
Mkt. cap
152.78B
Avg. vol.
269.95K
Volume
332.11K
P/E ratio
114.10
52-wk high
SEKÂ 487.00
52-wk low
SEKÂ 293.60
EPS
SEKÂ 3.74
Shares outstanding
357.64M
No. of employees
2K
Open
SEKÂ 433.60
High
SEKÂ 437.40
Low
SEKÂ 420.40
Mkt. cap
152.78B
Avg. vol.
269.95K
Volume
332.11K
P/E ratio
114.10
52-wk high
SEKÂ 487.00
52-wk low
SEKÂ 293.60
EPS
SEKÂ 3.74
Shares outstanding
357.64M
No. of employees
2K
News stories
From web sources and news partners
HDFC Sky
·
23 minutes ago
US Stocks End Mixed as Chip Selloff Hits Nasdaq
TradingView
·
1 hour ago
Dow, S&P 500, Nasdaq Futures Mixed Amid Rising Oil Prices Ahead Of CPI Data: BAC, RIVN, SLS, GME Stocks In Focus
å·´å£«çš„å ±
·
1 hour ago
U.S. stocks end lower amid chip selloff
Profile
Sobi - Swedish Orphan Biovitrum AB is an international biopharmaceutical company focused on rare diseases. The company develops, commercializes, and delivers therapies in the fields of haematology, immunology and specialty care. Headquartered in Stockholm, Sweden, with major hubs in Basel, Switzerland, and Waltham, USA.
Sobi has a global presence in approximately 30 countries and provides medicines to patients in many more around world. The company develops treatments for patients living with complex and chronic rare conditions and maintains a pipeline of development and lifecycle management programs focused on advancing innovative therapies for diseases with significant unmet medical needs. Wikipedia
About Swedish Orphan Biovitrum AB (publ)